Guy Miller, MD, PhD
Guy Miller, MD, PhD is Chairman and Chief Executive Officer of Edison Pharmaceuticals, Inc. Edison is focused on the development of drugs for rare childhood diseases; its lead clinical candidate, Vincerinone™, is in late-stage clinical development. Prior to founding Edison, Dr. Miller was the founder and Chief Executive Officer of Galileo Laboratories. Dr. Miller holds a PhD in chemistry and an MD, with subspecialty training in critical care medicine. He completed his residency, fellowship and was an assistant professor at Johns Hopkins, and is currently a member of the voluntary faculty at Stanford University Medical Center as anattending physician in medical-surgical critical care.
Dr. Miller will speak about challenges associated with the discovery and development of drugs for rare pediatric mitochondrial diseases, and applications to adult neurodegenerative diseases.